BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8110491)

  • 1. Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss.
    Denz H; Orth B; Weiss G; Gallati H; Herrmann R; Huber P; Wachter H; Fuchs D
    Eur J Cancer; 1993; 29A(16):2232-5. PubMed ID: 8110491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation.
    Zangerle R; Gallati H; Sarcletti M; Weiss G; Denz H; Wachter H; Fuchs D
    J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):79-85. PubMed ID: 7903382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma.
    Piccinini L; Zironi S; Cenci AM; Campioli D; Federico M; Barbieri F
    Eur J Clin Chem Clin Biochem; 1993 Sep; 31(9):567-74. PubMed ID: 8260527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease.
    Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
    Leukemia; 1993 Sep; 7(9):1339-43. PubMed ID: 8396696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Abe S; Inoue S; Hino T; Saito H; Yuki H; Kato S; Tomoike H
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1179-84. PubMed ID: 10764309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever.
    Samsonov MY; Tilz GP; Pisklakov VP; Reibnegger G; Nassonov EL; Nassonova VA; Wachter H; Fuchs D
    Clin Immunol Immunopathol; 1995 Jan; 74(1):31-4. PubMed ID: 7994924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis.
    Samsonov MY; Nassonov EL; Tilz GP; Geht BM; Demel U; Gurkina GT; Shtutman VZ; Guseva AG; Wachter H; Fuchs D
    Br J Rheumatol; 1997 Jun; 36(6):656-60. PubMed ID: 9236675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria.
    Deloron P; Roux Lombard P; Ringwald P; Wallon M; Niyongabo T; Aubry P; Dayer JM; Peyron F
    Eur Cytokine Netw; 1994; 5(3):331-6. PubMed ID: 7948768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters.
    Nachbaur DM; Herold M; Maneschg A; Huber H
    Ann Hematol; 1991; 62(2-3):54-8. PubMed ID: 2031968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss in patients with hematological neoplasias is associated with immune system stimulation.
    Denz H; Orth B; Weiss G; Herrmann R; Huber P; Wachter H; Fuchs D
    Clin Investig; 1993 Jan; 71(1):37-41. PubMed ID: 8453258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
    Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
    Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
    J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cause-effect relations between 55 kD soluble TNF receptor concentrations and specific and unspecific symptoms in a patient with mild SLE disease activity: an exploratory time series analysis study.
    Schubert C; Haberkorn J; Ocaña-Peinado FM; König P; Sepp N; Schnapka-Köpf M; Fuchs D
    BMC Res Notes; 2015 Sep; 8():465. PubMed ID: 26391351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients.
    Salles G; Bienvenu J; Bastion Y; Barbier Y; Doche C; Warzocha K; Gutowski MC; Rieux C; Coiffier B
    Br J Haematol; 1996 May; 93(2):352-9. PubMed ID: 8639428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
    Diez-Ruiz A; Tilz GP; Zangerle R; Baier-Bitterlich G; Wachter H; Fuchs D
    Eur J Haematol; 1995 Jan; 54(1):1-8. PubMed ID: 7859870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis.
    Diez-Ruiz A; Tilz GP; Gutierrez-Gea F; Gil-Extremera B; Murr C; Wachter H; Fuchs D
    Hepatology; 1995 Apr; 21(4):976-8. PubMed ID: 7705808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients.
    Rathore VB; Advani SH; Nadkarni JJ
    Cancer Detect Prev; 1999; 23(3):226-31. PubMed ID: 10337001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitis.
    Humbert M; Roux-Lombard P; Cerrina J; Magnan A; Simonneau G; Dartevelle P; Galanaud P; Dayer JM; Emilie D
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1681-5. PubMed ID: 8004330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.